U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07851623) titled 'Evaluation of Safety, Side Effects, and How the Drug, Inhaled CHF10136, Is Absorbed, Modified and Removed From the Body in Healthy Adults and Adults With Asthma' on Sept. 18.
Brief Summary: This study evaluates the safety and tolerability of CHF10136 administered by inhalation in healthy adults and adults with asthma. The study includes single-dose, multiple-dose, and repeated-dose treatment periods and will also characterize the pharmacokinetic profile of CHF10136.
Study Start Date: Oct. 01
Study Type: INTERVENTIONAL
Condition:
Asthma
Healthy Volunteers
Intervention:
DRUG: CHF10136
CHF10136 powder for inhalation administered ...